Basilea Pharmaceutica AG Allschwil, BSLN:SWX directors and dealings

Health CarePharmaceuticals and Biotechnology

Price (CHF)41.30
Today's Change0.75 / 1.85%
Shares traded34.24k
1 Year change+15.52%
Beta1.0767

Data delayed at least 15 minutes, as of Nov 22 2024 16:30 GMT.

More ▼

Add to Your Portfolio

Name

Currency

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

Name	Title	Compensation	Age	Officer since
Domenico Scala	Non-Executive Independent Chairman of the Board	262.41kCHF	58	2013
David Veitch	Chief Executive Officer, Member of the Management Committee	1.13mCHF	59	2014
Thomas Werner	Non-Executive Independent Vice Chairman of the Board	173.76kCHF	68	2018
Adesh Kaul	Member of the Management Committee, Chief Financial Officer	--	49	2019
Gerrit Hauck	Member of the Management Committee, Chief Technology Officer	--	59	2018
Laurenz Kellenberger	Member of the Management Committee, Chief Scientific Officer	--	57	2009
Damian Heller	General Counsel, Corporate Secretary	--	58	2017
Peter Bielmeier	Head of Global Quality Management	--	57	2022
Stephan Braun	Chief Medical Officer	--	--	2024
Ursula Eberhardt	Head of Global Human Resources	--	62	2017
Marc Engelhardt	Member of the Management Committee, Chief Medical Officer	--	60	2018
Leonard Kruimer	Non-Executive Independent Director	140.13kCHF	66	2022
Alf Nicklasson	Non-Executive Independent Director	163.68kCHF	69	2013
Nicole Onetto	Non-Executive Independent Director	145.38kCHF	71	2017
Carole Sable	Non-Executive Independent Director	145.38kCHF	63	2023
Peer Schroeder	Head of Corporate Communications, Investor Relations	--	--	2016

More ▼

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Basilea Pharmaceutica AG Allschwil

Select symbol

Basilea Pharmaceutica AG Allschwil

ApplyActions

Your alerts

Directors & Officers